You may remember us from last year, when you voted for us and generously donated $20,000! Want to know where that went?

With your help, we are now ready to trial our coronary stents in humans. We have proved concretely that our stents, which we coat in bio-compatible materials using state of the art plasma-physics technology, work. Our stents last longer, and mean people will not have to rely on blood-thinning medication, with its damaging side effects, for the rest of their lives.

With your help, we are now at the point of patenting our groundbreaking discovery: a new class of nanoparticle that has the potential to revolutionise drug delivery and make treatments more effective for a wide range of diseases including heart disease, Alzheimer's and cancer.

With your help, we are about to publish the results of our unique work on spinning silk into replacement blood vessels.


Cardiovascular disease is the world’s biggest killer, and affects 2 out of every 3 Australian families. The Heart Research Institute’s research is ground-breaking, and life-saving.   

Your vote and your donation this year will enable more breakthroughs in cutting-edge bio-engineering next year. Today's research is tomorrow's cure.

  1. Vote heart and secure Optiver’s 2017 donation for our cutting edge research. 
  2. Tell all your friends and get them to vote for us too! 



  • The HRI research facilities at Eliza St, Newtown run off a rooftop system of 365 solar panels, with a rated power output of 96.725kW. This helps to decrease our cost of utilities. 

  • The discovery of a new class of bioactive nanoparticles by the HRI’s Applied Materials Group was serendipitous. Researchers were curious about the microscopic particles contaminating a smooth stent coating. Made of stardust – the same substance that makes up our galaxy – up to a billion nanoparticles can fit on the head of a pin.

  • In 2017, HRI had over 151 collaborations across 21 countries with some of the world’s leading scientific organisations including: The SCRIPPS Research Institute (USA), Stanford University (USA), Harvard University (USA), The University of Cambridge (UK), Oxford University (UK) and Auckland University (New Zealand).

  • The HRI Applied Materials Group is working to develop the next generation of bioactive materials – materials that can bond to living tissues. One of these projects is investigating the use of silk from silk worm cocoons as a material for the engineering of artificial blood vessels.

  • The HRI drives the cardiovascular research node at the Charles Perkins Centre at The University of Sydney. The mission of the Centre – named in honour of The University of Sydney alumnus Dr Charles Perkins, who was the first Aboriginal man to graduate from an Australian university – is to ease the burden of obesity, diabetes and cardiovascular disease.

  • There are now more than 50,000 people across Australia, New Zealand, Canada and the United Kingdom, who give to the HRI on a monthly basis, and many thousands more who donate quarterly or once a year.

  • The HRI’s ultrapure water system purchased this year provides water that is ultrapure, sterile, and most importantly, free of endotoxins – molecules which can contaminate labware and significantly impact experiment results. This is critical when water is used in cell culture work.
[gravityform id="101" title="false" description="false"]